Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Novel Multiplexed Protein Sensor Developed

By LabMedica International staff writers
Posted on 14 Aug 2013
A novel method has been developed for parallel protein analysis that is, in principle, capable of identifying hundreds or even thousands of different proteins.

The device is able to identify the specific proteins in the fluid and allows rapid and reliable differentiation between harmless microorganisms and dangerous pathogens. More...


Chemists at Johannes Gutenberg University (Mainz, Germany) have designed a sensor that is only of one-tenth of a square millimeter in area, but capable of performing a hundred different individual tests on that surface. The 'test strips' consist of glass capillary tubes that have gold nanoparticles as sensor elements on their internal surfaces. The test involves placing a tiny drop of blood, saliva, or other bodily fluid on a small test strip, which is then placed in the device.

The scientists used the simple and direct principle of plasmons in noble metal nanoparticles, which react to protein binding by a shift of the resonance wavelength. This is the target detection method for both the mapped and the unmapped sensors by monitoring individual nanoparticles by optical dark-field spectroscopy. The team used four different target proteins to demonstrate the viability of the concept, its ability to detect concentrations in the nanomolar range, and the possibility to recycle the sensors for more than one analysis.

The four proteins tested were thrombin, immunoglobulin E (IgE), streptavidin, and fibronectin. When a protein docks with one of these special DNA strands, called aptamers, the corresponding nanoparticle changes its color. The color changes can be detected with the aid of a spectrometer. For this purpose, the capillary tubes are placed under a microscope designed, constructed, and provided with the necessary software by the team of chemists. Low-cost serial production of the sensors is feasible if advanced nanofabrication methods such as nanoprinting or optical trapping are used.

Christina Rosman, DiplChem, first author of the study, said, “We have demonstrated a new approach for a multiplexed assay that detects multiple proteins simultaneously by letting a fluid flow past the randomly positioned gold nanorods. We see the potential to extend our method to the simultaneous detection of hundreds or even thousands of different target substances." There are manifold possible applications of a test for multiple targets in a single procedure. The low-cost sensors could be directly used by physicians in their practices in order to detect and discriminate various types of influenza viruses with which their patients could be infected. The study was published on June 21, 2013, in the journal Nano Letters.

Related Links:

Johannes Gutenberg University



New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.